Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives.

about

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives.

Item

http://www.wikidata.org/entity/Q52370841

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@en

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@nl

type

Item

label

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@en

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@nl

prefLabel

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@en

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@nl

P1476

Study of the Serum Metabolomic ...... rch and Clinical Perspectives.

@en

P2093

Erica Villa

http://www.w3.org/2001/XMLSchema#string

Pietro Andreone

http://www.w3.org/2001/XMLSchema#string

Stefano Gitto

http://www.w3.org/2001/XMLSchema#string

P2860

HMDB 3.0--The Human Metabolome Database in 2013

Update of the LIPID MAPS comprehensive classification system for lipids

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases

Treatment of nonalcoholic steatohepatitis in adults: present and future

Biomarkers in nonalcoholic fatty liver disease

The influence of pharmacogenetics on fatty liver disease in the wistar and kyoto rats: a combined transcriptomic and metabonomic study

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease

The metabolomic window into hepatobiliary disease.

P31

scholarly article

P356

10.3390/METABO8010017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Schepis

P577

2018-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29495258

http://www.w3.org/2001/XMLSchema#string

P932

5876006

http://www.w3.org/2001/XMLSchema#string